Nakahata · Science (New York, N.Y.) 2009 · in vitro mechanistic laboratory study · n=?

Circadian control of the NAD+ salvage pathway by CLOCK-SIRT1.

Cited 1183 times in the scientific literature.

Level 5 - mechanism / opinion, no new human data

Preclinical in vitro mechanistic study in mouse cells (Oxford CEBM Level 5).

PubMed 19286518 · doi:10.1126/science.1170803 · record verified 2026-08-30

What was done

Investigators evaluated the molecular link between the core circadian clock and NAD+ metabolism in mouse embryo fibroblasts. They analyzed 24-hour intracellular NAD+ rhythms, assessed the binding and regulation of the Nampt promoter by the CLOCK:BMAL1 complex and SIRT1, and tested the necessity of NAMPT for circadian gene expression using the pharmacological inhibitor FK866.

What was found

Intracellular NAD+ levels oscillated in a 24-hour circadian rhythm driven by the cellular clock. The CLOCK:BMAL1 heterodimer regulated the expression of Nampt, and SIRT1 localized to the Nampt promoter to modulate biosynthesis of its coenzyme. Inhibition of NAMPT with FK866 altered circadian gene expression. The abstract reports no numerical values, effect sizes, or test statistics.

Why it matters

This paper identifies an interlocked enzymatic and transcriptional feedback loop directly linking circadian clock proteins to cellular energy metabolism via NAD+ biosynthesis.

Limits

All findings reported in the abstract are from in vitro mouse embryo fibroblasts, so direct applicability to in vivo mammalian tissue or human physiology is unmeasured. The abstract does not provide sample sizes, quantitative measurements, or variance data.

Cited by